EODData

MEMBERSHIP REGISTER LOG IN

FRA, L1PA: LEE S PHARMACEUTIC.HD-05

02 Oct 2025
LAST:

0.2360

CHANGE:
 0.01		OPEN:
0.2400		HIGH:
0.2400		ASK:
0.0000		VOLUME:
0
CHG(%):
4.42		PREV:
0.2260		LOW:
0.2360		BID:
0.0000		 

CHART

RECENT END OF DAY PRICES

DateOpenHighLowCloseVolume
02 Oct 250.24000.24000.23600.23600
01 Oct 250.22600.22600.22600.22600
30 Sep 250.23200.23200.23000.23000
29 Sep 250.24600.24600.24400.24400
26 Sep 250.24600.24600.24400.24409.4K
25 Sep 250.24400.24400.24400.24409.4K
24 Sep 250.24000.24200.24000.24209.4K
23 Sep 250.24800.25200.24800.25009.4K
22 Sep 250.25200.25200.25200.25209.4K
19 Sep 250.26200.26600.26200.26409.4K

COMPANY PROFILE

Name:LEE S PHARMACEUTIC.HD-05
About:Lee's Pharmaceutical Holdings Limited, an investment holding company, develops, manufactures, markets, and sells pharmaceutical products in the People's Republic of China, Hong Kong, and internationally. It focuses on various disease areas, such as cardiovascular, woman's health, pediatrics, rare diseases, oncology, dermatology, and obstetrics. It operates in Proprietary and Generic Products; and Licensed-In Products segments. The Proprietary and Generic Products segment manufactures and sells Nadroparin Calcium injection and Livaracine to treat blood clots and deep vein thrombosis; Yallaferon for viral infection; Slounase for hemostasis; Socazolimab Injection for Recurrent or metastatic cervical cancer; Treprostinil injection for pulmonary arterial hypertension; fondaparinux sodium injection for deep vein thrombosis; and Sodium Phenylbutyrate Granules to treat urea cycle disorders; Apremilast Tablets for Plaque psoriasis; and Azilsartan Tablets for hypertension. The Licensed-In Products segment offers Sancuso for chemotherapy induced nausea and vomiting; Bredinin to treat Immunosuppression in renal transplantation; Centraxal Plus for acute otitis media with tympanostomy tubes; and Ferplex to treat iron deficiency anemia. This segment also offers Intrarosa for vulvovaginal atrophy; Adasuve for agitation associated with schizophrenia or bipolar I disorder in adults; Mictonorm for urinary incontinence; Natulan for Stage III and IV Hodgkin's disease; Lutrate for Prostate cancer; Nitric Oxide for Inhalation for Hypoxic respiratory failure associated with pulmonary hypertension; Omacor to treat Omega-3-acid ethyl esters; Zanidip for hypertension; Readyfusor for post-operative pain management; Teglutik to treat Amyotrophic lateral sclerosis; Trittico for insomnia/depression; Dicoflor and VSL#3 for probiotics; and Zingo for topical local analgesics. The company was founded in 1994 and is headquartered in Shatin, Hong Kong.
Sector:Healthcare
Address:Building 20E, Shatin, Hong Kong
Website:https://www.leespharm.com
ISIN:KYG5438W1116

API SERVICE  NEW

Have you tried our new API Service yet?

For more information, visit our API page.

You can get your ApiKey over HERE.

If you're ready to get going, then jump over to:
https://api.eoddata.com

SYMBOL HISTORY

   Add to Watchlist

DOWNLOAD DATA

Download stock quote history quickly and easily in a variety of formats to suit your needs.

  Download

FUNDAMENTALS

P/E Ratio:12.20
DivYield:0.19
Div/Share:0.05
Price to Book:0.63
Price to Sales:0.10
EBITDA:216.46M
Shares:588.84M
Market Cap:138.97M

TECHNICAL INDICATORS

MA5:0.24
MA10:0.24
MA20:0.24
MA50:0.21
MA100:0.18
MA200:0.17
STO9:38.46
STO14:44.44
RSI14:53.97
WPR14:-55.56
MTM14:0.02
ROC14:0.10
ATR:0.01
Week High:0.25
Week Low:0.23
Month High:0.27
Month Low:0.21
Year High:0.27
Year Low:0.13
Volatility:106.15

RECENT DIVIDENDS

Date Amount
28 May 2025$0.00
12 Sep 2024$0.00
28 May 2024$0.00
12 Sep 2023$0.00
25 May 2023$0.00
08 Sep 2022$0.00
26 May 2022$0.00
15 Sep 2021$0.00
31 May 2021$0.00
14 Sep 2020$0.00